Highlights

  • The US IPO was priced at US$4.25 for 4,705,883 common shares.
  • Trading under the AMRO symbol was expected to begin on 15 October 2026.
  • A 30-day underwriters’ option covers up to 705,882 additional shares.
  • Up to approximately US$10.0 million is intended for capital equipment.
  • The company’s separate proposed-issue notice specifies a larger potential share total.

Amaero Inc. (ASX:3DA) manufactures high-temperature refractory and titanium alloy powders for additive manufacturing and develops near-net-shape components using powder metallurgy and hot isostatic pressing (PM-HIP). With manufacturing operations in Tennessee, the company announced the pricing of a United States initial public offering on 15 October 2026, marking a further step in its US capital-market plans.

US Offering Price and Proposed Listing

Amaero Inc. (ASX:3DA) priced its offering of 4,705,883 common shares at US$4.25 per share. The company stated that trading on the Nasdaq Capital Market was expected to begin on 15 October 2026 under the symbol AMRO. Closing was expected on 16 October 2026, subject to customary conditions; pricing alone did not establish that the transaction had closed.

The underwriters received a 30-day option to acquire up to another 705,882 shares at the offering price, less underwriting discounts and commissions. The announced base offering represents approximately US$20.0 million before costs, calculated from the stated share count and issue price.

What the Separate Securities Notice Shows

A separate ASX proposed-issue notice referred to 5,411,765 common shares at US$4.25 each, with a proposed issue date of 16 October 2026. That number exceeds the 4,705,883 shares covered by the priced base offering by 705,882 shares, equal to the underwriters’ option. The filings do not explicitly reconcile the two totals, so the ultimate issue size depends on subsequent confirmation.

The notice described 5,000,000 shares under a shareholder-approved underwritten offering and 411,765 shares under the company’s placement capacity. For Amaero Inc. (ASX:3DA), the distinction matters because the number of shares ultimately issued affects the amount of capital raised and the enlarged share base.

Planned Deployment of IPO Proceeds

Amaero said up to approximately US$10.0 million of offering proceeds would be directed towards capital equipment purchases over the following 12 months. Remaining funds were intended for general corporate purposes, including working capital, operating expenditure and research and development. These allocations were stated intentions rather than completed investments.

The company’s Tennessee operations produce specialty alloy powders used in demanding industrial applications, including defence and aerospace manufacturing. No individual equipment purchases or capacity additions were specified.

Capital Structure and Execution Considerations

Amaero Inc. (ASX:3DA) remains quoted under its existing ASX code alongside the proposed US listing. Its ASX securities are Chess Depositary Interests, with a 40-to-1 ratio to common shares noted in the company’s pricing explanation.

The registration statement on Form S-1 was declared effective by the US Securities and Exchange Commission on 14 October 2026. However, the offering was still subject to closing conditions at the time of the announcement.

Key Insights

The 15 October 2026 disclosure sets out the pricing and intended use of proceeds for Amaero Inc. (ASX:3DA), but leaves completion and final issuance to subsequent transaction steps. The separate proposed-issue notice and the underwriters’ option explain why the disclosed share totals differ. The company’s manufacturing strategy provides the commercial context, while actual funds received and deployed will depend on the completed offering.